MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

MDT

96.46

-0.47%↓

A

146.44

-1.03%↓

VEEV

228.35

-1.98%↓

HQY

84.03

-0.27%↓

PHR.US

16.54

-3.44%↓

Search

Globus Medical Inc (Class A)

Fermé

SecteurSoins de santé

90.26 -1.58

Résumé

Variation du prix de l'action

24h

Actuel

Min

88.46

Max

91.68

Chiffres clés

By Trading Economics

Revenu

-84M

119M

Ventes

24M

769M

P/E

Moyenne du Secteur

30.573

90.831

BPA

1.18

Marge bénéficiaire

15.469

Employés

5,300

EBITDA

22M

215M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+10.02% upside

Dividendes

By Dow Jones

Prochains Résultats

19 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

4.1B

12B

Ouverture précédente

91.84

Clôture précédente

90.26

Sentiment de l'Actualité

By Acuity

25%

75%

63 / 361 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

Globus Medical Inc (Class A) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

13 janv. 2026, 19:05 UTC

Principaux Mouvements du Marché

Travere Therapeutics Shares Fall After FDA Extends Filspari Review

13 janv. 2026, 23:41 UTC

Market Talk

Nikkei May Rise on Japan Election Hopes -- Market Talk

13 janv. 2026, 23:41 UTC

Market Talk

Global Equities Roundup: Market Talk

13 janv. 2026, 23:33 UTC

Market Talk

Gold Edges Higher, Supported by Ongoing Geopolitical Tensions -- Market Talk

13 janv. 2026, 23:13 UTC

Acquisitions, Fusions, Rachats

JD Logistics Plans to Withdraw Listing Status of Deppon Logistics From Shanghai Stock Exchange

13 janv. 2026, 23:10 UTC

Acquisitions, Fusions, Rachats

JD Logistics Makes Cash Offer to Buy Deppon Logistics Shares It Doesn't Already Own

13 janv. 2026, 23:03 UTC

Market Talk

Woodside's Sales Revenue Likely Fell 13% in 4Q -- Market Talk

13 janv. 2026, 21:50 UTC

Acquisitions, Fusions, Rachats

Netflix Preparing to Make Warner Bid All-Cash -- WSJ

13 janv. 2026, 21:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Basic Materials Roundup: Market Talk

13 janv. 2026, 21:20 UTC

Acquisitions, Fusions, Rachats

Versant Media: Katz Will Continue to Lead Day-To-Day Ops of FTN

13 janv. 2026, 21:20 UTC

Acquisitions, Fusions, Rachats

Versant Media: Transaction Strengthens Distribution Footprint and Expands Free-To-Watch Portfolio >VSNT

13 janv. 2026, 21:20 UTC

Acquisitions, Fusions, Rachats

Versant Media: Jonathan Katz, FTN's Founder, Has Joined VERSANT, Reporting to David Pietrycha >VSNT

13 janv. 2026, 21:15 UTC

Acquisitions, Fusions, Rachats

VERSANT Completes Acquisition Of Free TV Networks >VSNT

13 janv. 2026, 21:08 UTC

Acquisitions, Fusions, Rachats

Array Digital Infrastructure Declares Special Dividend of $10.25 >AD

13 janv. 2026, 20:39 UTC

Market Talk

Silver Settles at Another New High -- Market Talk

13 janv. 2026, 20:21 UTC

Market Talk

Oil Futures Extend Rally On Rising Iran Tensions -- Market Talk

13 janv. 2026, 20:17 UTC

Market Talk

U.S. Natural Gas Edges Up on Coming Weather -- Market Talk

13 janv. 2026, 19:08 UTC

Acquisitions, Fusions, Rachats

Super Micro Computer Is an AI Winner. Sell the Stock Anyway, Goldman Sachs Says. -- Barrons.com

13 janv. 2026, 19:03 UTC

Résultats

Double-Digit Earnings Growth Could Continue. It Still Might Not Satisfy Investors. -- Barrons.com

13 janv. 2026, 18:50 UTC

Résultats

JPMorgan's Unusual Quarter Weighs on Shares. How Apple Plays a Role. -- Barrons.com

13 janv. 2026, 17:54 UTC

Market Talk

UnitedHealth Reaffirms 2025 Guidance After Senate Report -- Market Talk

13 janv. 2026, 17:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Global Equities Roundup: Market Talk

13 janv. 2026, 17:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Netflix Will Be a Winner No Matter How Warner Saga Ends -- Market Talk

13 janv. 2026, 17:49 UTC

Market Talk

Analysts Call For Potential Record Ethanol Output -- Market Talk

13 janv. 2026, 17:38 UTC

Market Talk

Merck CEO Sees $5B Market for Cidara's Flu Antiviral -- Market Talk

13 janv. 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

13 janv. 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

13 janv. 2026, 17:20 UTC

Market Talk
Acquisitions, Fusions, Rachats

Basic Materials Roundup: Market Talk

13 janv. 2026, 17:19 UTC

Market Talk

Credit Cards Present Opportunity, Potential Obstacle for JPMorgan -- Market Talk

13 janv. 2026, 17:15 UTC

Market Talk

Merck CEO Sees Eventual Growth After Keytruda Exclusivity Expires -- Market Talk

Comparaison

Variation de prix

Globus Medical Inc (Class A) prévision

Objectif de Prix

By TipRanks

10.02% hausse

Prévisions sur 12 Mois

Moyen 104.1 USD  10.02%

Haut 118 USD

Bas 87 USD

Basé sur 13 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

13 ratings

9

Achat

4

Maintien

0

Vente

Score Technique

By Trading Central

72.18 / 73.07Support & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

63 / 361Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Globus Medical Inc (Class A)

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
help-icon Live chat